MedTrace Logo

Concomitant CC and E2 Versus CC Alone in Ovulation Induction

NCT02186782 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2017-03-22

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of concomitant administration of estradiol during use of clomiphene citrate (CC) for induction of ovulation in infertile women.

Conditions

Interventions

DRUG

Clomiphene citrate and Estradiol

Women will receive clomiphene citrate (100 mg/day for 5 consecutive days from day 2 of cycle) and estradiol (2 mg/day for 5 consecutive days from day 2 of cycle)

DRUG

Clomiphene citrate and Placebo

Women will receive clomiphene citrate (100 mg/day for 5 consecutive days from day 2 of cycle) and placebo (for 5 consecutive days from day 2 of cycle)

Sponsors & Collaborators

  • Maher elesawi kamel elesawi

    lead OTHER

Principal Investigators

  • Ahmed M Badawy, Prof · Mansoura University

  • Maher E Kamel Elesawi, Dr · Mansoura University

  • Mohamed S Abdelhafez, Dr · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2018-07-31
Completion
2018-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02186782 on ClinicalTrials.gov